2,5-Dimethyl Celecoxib Induces Apoptosis and Autophagy Via Activation of ROS/JNK Axis in Nasopharyngeal Carcinoma Cells

Tan,Xiangjie Fu,Jiaquan Qu,Miao Zhang,He Chen,Yaochun Wang,Bo Wang,Juan Li,Jie Liu,Peijun Liu
DOI: https://doi.org/10.18632/aging.203488
2021-01-01
Aging
Abstract:2,5-dimethyl celecoxib (DMC), a close derivative of celecoxib, has also been reported to have anticancer effects. However, the effects and underlying molecular mechanisms of DMC with respect to nasopharyngeal carcinoma are still largely unknown. In this study, we present that DMC has displayed anticancer potency in nasopharyngeal carcinoma in vitro and in vivo. Mechanistically, we found DMC induced apoptosis and autophagy for anticancer therapy against nasopharyngeal carcinoma. Furthermore, DMC-induced autophagy could remarkably attenuate after the treatment of reactive oxygen species (ROS) scavenger N-acetyl cysteine (NAC) and c-Jun N-terminal kinase (JNK) inhibitor SP600125 (SP). Taken together, these results suggested DMC induced apoptosis and autophagic death via activation of ROS/JNK axis in NPC cells, which providing us new insights into developing potential therapeutic agents for nasopharyngeal carcinoma patients.
What problem does this paper attempt to address?